EQUITY RESEARCH MEMO

Anywhere Dx

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)45/100

Anywhere Dx is a Boston-based diagnostics company founded in 2020, developing a fully disposable, single-use diagnostic platform designed for consumer use. The company's mission is to make high-quality, lab-accurate testing fast, affordable, and accessible anywhere, addressing the limitations of current testing solutions that are too expensive, not scalable, and not accessible. By empowering individuals with direct control over their health, Anywhere Dx aims to disrupt the traditional diagnostics market. While the company is still in early stages (pre-revenue, pre-FDA clearance), its focus on consumer-centric, point-of-care testing aligns with growing demand for decentralized healthcare. Key risks include regulatory hurdles, manufacturing scalability, and competition from established players. The company's progress will depend on successful technology validation, regulatory submissions, and securing funding for commercialization.

Upcoming Catalysts (preview)

  • Q4 2026FDA Submission or 510(k) Clearance for Lead Test30% success
  • Q3 2026Strategic Partnership with Retail or Pharmacy Chain40% success
  • Q2 2026Series A Funding Announcement60% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)